NIH-funded research NIH-funded research

Scalable tools to help primary care detect Alzheimer’s disease earlier

Official title: Implementing Scalable Tools in Primary Care for Early Alzheimer’s Disease Detection Across a Health System

Funded at University of Kansas Medical Center · NIH-11344231 · Data updated 2026-11-12

A nationwide approach helps primary care teams use new tools and blood tests to diagnose Alzheimer’s disease Earlier and more accurately.

More s Disease research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Kansas Medical Center
NIH-funded
Lab location1 site (Kansas City, United States)
Project startJuly 1, 2026
Project endJune 30, 2030
Funding year2026
Award (this year)$3,254,395
NIH project number1RF1AG100511-01
Project IDNIH-11344231 on NIH RePORTER

Who could benefit from this research

Could help

Older adults at risk for or suspected of having ADRD who receive care in participating primary clinics.

Less likely to help

Patients unlikely to be affected are those without ADRD symptoms or not seen in the participating clinics.

What this research studies

This project rolls out a program in 15 primary care clinics to support doctors in identifying Alzheimer’s disease and related dementias sooner. It combines structured memory tests, a blood biomarker (p-tau217), smart decision support in the electronic health record, and specialty clinics that team with PCPs. The plan uses a pragmatic stepped-wedge design to see how well the approach works in real-world practice and to understand what makes it easier or harder to adopt. Training for frontline clinicians and clinical champions aims to sustain improvements in care pathways. Results will be assessed with both clinical outcomes and implementation metrics to guide future spread.

Why it matters

Potential benefit: If successful, patients may receive earlier, more accurate diagnoses and faster access to appropriate care and therapies.

How similar studies have gone: Prior studies show that integrated PCP tools and biomarkers can improve dementia detection, but large-scale primary-care implementation is still developing.

Where this research is happening

  • University of Kansas Medical Center
    Kansas City, United States
    Active

Researchers

  • Principal investigator: Burns, Jeffrey Murray — University of Kansas Medical Center
  • Study coordinator: Burns, Jeffrey Murray

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.